For the quarter ending 2025-10-31, QTZM had -$400 decrease in cash & cash equivalents over the period.
| Cash Flow | 2025-10-31 | 2025-07-31 |
|---|---|---|
| Net loss | 49,868 | 199,269 |
| Gain on extinguishment of debt | - | 2,500 |
| Prepaid expenses | 0 | -10,000 |
| Accounts payable | 30,355 | 65,438 |
| Due to related party | -400 | 1,150 |
| Net cash used from operating activities | -19,913 | -125,181 |
| Proceeds from the issuance of common stock | 0 | 41,850 |
| Proceeds from notes payable | 19,513 | 83,915 |
| Net cash from financing activities | 19,513 | 125,765 |
| Net increased (decrease) in cash | -400 | 584 |
| Cash and cash equivalents at beginning of period | 584 | 0 |
| Cash and cash equivalents at end of period | 184 | 584 |
Quantumzyme Corp. (QTZM)
Quantumzyme Corp. (QTZM)